Health

InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis

BEIJING, Nov. 27, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the…

3 weeks ago

Eisai Submits New Drug Application for Subcutaneous Formulation of LEQEMBI for the Treatment of Early Alzheimers Disease in Japan

If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the…

3 weeks ago

Advanced Radiotherapy is a game-changer for India’s cancer care burden

MUMBAI, India, Nov. 27, 2025 /PRNewswire/ -- In a country with over 1.4 million[i] cases reported annually, with most being…

3 weeks ago

B Prabhakaran visits Lloyds Kali Ammal Memorial (LKAM) Hospital to celebrate the milestone of 300th Baby Delivery

~B Prabhakaran, MD of Lloyds Metals and Energy Ltd. reinforces the commitment to accessible, quality healthcare in the region of…

3 weeks ago

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting

November 26, 2025 19:00 ET  | Source: HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 27,…

3 weeks ago

Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and Fourth Consecutive Quarter of Profitability, Highlighting Strong Multi-Vertical Performance

“The quarter reflects broad growth across all verticals, expanding VSDHOne adoption, and strategic investments aimed at supporting margin improvement and…

3 weeks ago

Young Minds Explore Creativity, Teamwork, and Healthy Habits at Manipal Hospital Yelahanka’s Children’s Day Event

BENGALURU, India, Nov. 26, 2025 /PRNewswire/ -- 'Healthy childhood is the foundation on which healthy adulthood is built.'  - This…

3 weeks ago

Apollo Hospitals rolls out its third facility in Maharashtra with a 400-bed quaternary care facility in Pune

PUNE, India, Nov. 24, 2025 /PRNewswire/ -- Apollo Hospitals, Asia's pioneering integrated healthcare services provider, today inaugurated its newest facility in…

3 weeks ago

Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate

Antibody levels remained well above baseline across all six serotypes and age groups sixth month after third yearly booster doseNo…

3 weeks ago

Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference

Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference Schlieren (Zürich), Switzerland, November 26, 2025 – Kuros…

3 weeks ago